January 10, 2018

Vitor Rocha succeeds Brent Shafer as CEO of Philips North America

Amsterdam, the NetherlandsRoyal Philips (NYSE: PHG, AEX: PHIA) today announced that Vitor Rocha, who previously led Philips’ global Ultrasound business, has succeeded Brent Shafer as CEO of Philips North America, with immediate effect. Mr. Rocha has joined Philips’ Executive Committee and reports to Philips CEO Frans van Houten. Mr. Shafer, who joined Philips in 2005, will leave Philips per January 31, 2018, to become CEO of a listed company in the US. 


“I want to thank Brent for his valuable contribution to Philips’ transformation into a health technology leader at a time of significant market changes in North America,’’ said Frans van Houten, CEO of Royal Philips. “His dedication and leadership have made a difference throughout his tenure in the company. On behalf of Philips’ Executive Committee, I wish him all the best in his future endeavors. At the same time, I am very pleased to announce Vitor, a seasoned healthcare industry leader with a strong track record in innovation, entrepreneurship and customer-centricity, as his successor. Vitor’s health technology expertise, personal leadership and deep experience in the North American market will enable him to lead the expansion of Philips’ health technology leadership in the region. I am confident that the support and handover from Brent over the coming weeks will ensure a seamless transition.”


Mr. Rocha (Brazilian/American, 1969) has more than 20 years of leadership experience across multiple industries, and a particularly deep knowledge of medical device and health technology businesses. He joined Philips in 2010 as the leader of the Latin American market for Philips’ Healthcare sector. Through 2010-2014, he drove strong comparable sales growth and market share gains in one of the fastest growing and most volatile healthcare markets globally. He subsequently led Philips’ global Ultrasound business. Under his leadership, the EUR 1.5 billion business successfully executed on its strategy to strengthen its leading position in cardiac ultrasound, while accelerating growth in services, General Imaging, Point-of-Care and OB/GYN.  


Under Mr. Rocha’s new leadership of the North American market, Philips is committed to continue its strong delivery in this market with long-term strategic partnerships and new solutions [1]. The company has a significant R&D, industrial and commercial footprint in North America since 1933, partnering with major health systems, government agencies and charitable organizations. Philips generates approximately EUR 6.5 billion in sales [2] and employs approximately 21,000 employees in this market.


[1] Suites of systems, smart devices, software and services that Philips offers with its partners that are designed to improve people's health, enable better outcomes and enhance productivity across the health continuum from healthy living and prevention, to diagnosis, treatment and home care.

[2] Last twelve months Q3 2017.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 73,000 employees with sales and services in more than 100 countries. News about Philips can be found at

Click here to read moreClick here to read less

Forward-looking statements

This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.

Click here to read moreClick here to read less



Steve Klink

Steve Klink

Philips Global Press Office

Tel: +31 6 10888824

Ksenija Gonciarenko

Ksenija Gonciarenko

Philips Investor Relations

Tel: +31 20 59 77055

Media assets

Press releases

Get our press releases by e-mail

Share on social media

  • Link copied

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.